Original Research
Published on 09 Sep 2024
Head-to-head comparison of two human papillomavirus vaccines for efficacy against cervical intraepithelial neoplasia grade 3 and adenocarcinoma in situ—population-based follow-up of two cluster-randomized trials
in Virus and Host
- 3,202 views
- 1 citation